New autism drug tested at New Brunswick hospital APP.com Asbury Park Press: "'We are targeting the symptoms of autism,' said Dr. Joan Fallon, founder of Curemark LLC, a drug-research and development company located in Rye, N.Y. The company is testing its new product at 13 locations nationwide.
The testing being conducted at Saint Peter's involves 170 youngsters, hospital spokesman Phil Hartman said.
Fallon said the test pool covers children age 3 to 8. She said she expects results 'sometime early next year.'"
No comments:
Post a Comment